Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up (2016)
- Authors:
- USP affiliated authors: ANDRADE, JURANDYR MOREIRA DE - FMRP ; MOISÉS, ELAINE CHRISTINE DANTAS - FMRP ; CARRARA, HELIO HUMBERTO ANGOTTI - FMRP ; TIEZZI, DANIEL GUIMARÃES - FMRP
- Unidade: FMRP
- DOI: 10.1097/CAD.0000000000000344
- Subjects: ANTINEOPLÁSICOS; NEOPLASIAS MAMÁRIAS; QUIMIOTERAPIA ADJUVANTE; COMPLICAÇÕES NA GRAVIDEZ
- Keywords: Breast cancer; Oligohydramnios; Perinatal care; Pregnancy; Trastuzumab
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2016
- Source:
- Título: Anti-Cancer Drugs
- ISSN: 0959-4973
- Volume/Número/Paginação/Ano: v. 27, n. 4, p. 369-372, 2016
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
ANDRADE, Jurandyr Moreira de et al. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up. Anti-Cancer Drugs, v. 27, n. 4, p. 369-372, 2016Tradução . . Disponível em: https://doi.org/10.1097/CAD.0000000000000344. Acesso em: 31 mar. 2026. -
APA
Andrade, J. M. de, Brito, L. G. O., Moisés, E. C. D., Amorim, A. C., Rapatoni, L., Carrara, H. H. A., & Tiezzi, D. G. (2016). Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up. Anti-Cancer Drugs, 27( 4), 369-372. doi:10.1097/CAD.0000000000000344 -
NLM
Andrade JM de, Brito LGO, Moisés ECD, Amorim AC, Rapatoni L, Carrara HHA, Tiezzi DG. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up [Internet]. Anti-Cancer Drugs. 2016 ; 27( 4): 369-372.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1097/CAD.0000000000000344 -
Vancouver
Andrade JM de, Brito LGO, Moisés ECD, Amorim AC, Rapatoni L, Carrara HHA, Tiezzi DG. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up [Internet]. Anti-Cancer Drugs. 2016 ; 27( 4): 369-372.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1097/CAD.0000000000000344 - Quality of life in women with breast cancer treated with or without chemotherapy
- Cancer stem cells and lymph node metastasis in early stage breast cancer
- Clinicopathological characteristics and recurrence risk in patients with ductal carcinoma in situ of the breast
- Idade como fator independente de prognóstico no câncer de mama
- Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors
- Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
